More IPO Presentations: SurgiVision and Envestnet

SurgiVision is a company we are following because it crosses two major themes we like, health technology and real VR. However, the company is more development stage than we expected. The ability to do surgery based on vision from MRI does seem inevitable, and their technology appears ready, but the pace of adoption is hard to forecast. Because the company wants to build a recurring revenue, supply-based business, their revenue and profit ramp will be elongated. This deal is a bit of a public/private transaction to give the company the expansion capital needed to go to . . .

Want the rest of the article?

Please login or join us as a member to view our complete content!